Journal of Neurology, Neurosurgery & Psychiatry Submission Guide
A source-checked guide to JNNP fit, neurological evidence, article preparation, and submission readiness.
Readiness scan
Find out if this manuscript is ready to submit.
Run the Free Readiness Scan before you submit. Catch the issues editors reject on first read.
Quick answer: Submit to JNNP when the neurological, neurosurgical, or neuropsychiatric consequence is the manuscript's true center and the evidence can withstand a specialist review. Phenotype, design, analysis, validation, clinical meaning, and limitation should point to the same inference.
Evidence basis: We checked the official JNNP author page, journal home, and BMJ Author Hub on August 26, 2026. The publisher controls current requirements; Manusights supplies the decision framework.
This guide exists to connect those publisher requirements to the neurological claim, phenotype, evidence, reporting, and package decisions an author must make before upload.
This guide cannot predict acceptance or a private editorial decision; it helps authors test the public requirements and evidence chain before submission.
Evidence center | JNNP-ready question | Common mismatch |
|---|---|---|
Disease mechanism | What neurological mechanism does the evidence distinguish? | Correlation is described as mechanism |
Clinical course | Which prognosis or management decision becomes clearer? | A selected cohort is generalized too broadly |
Diagnostic method | Does the tool work against a credible reference and outside development? | Accuracy lacks calibration or external validation |
Intervention | Which patient-relevant outcome changes, with what uncertainty and harm? | Surrogate change becomes clinical benefit |
Pressure-test the JNNP inference.
From our manuscript review practice
The neurological consequence must survive contact with design, phenotype, and validation limits.
Make one neurological question own the manuscript
Multidisciplinary work can fit JNNP, but the paper still needs one editorial owner. Imaging, genetics, computation, surgery, psychiatry, pathology, or epidemiology should resolve a neurological question rather than compete as a separate methods paper. A removal test helps: if removing the disease or nervous-system context leaves the central conclusion intact, a different venue may own the work.
Define phenotype and ascertainment with enough precision that another specialist could recognize who is and is not represented. Disease stage, treatment history, referral setting, comorbidity, outcome definition, and follow-up often control whether a result travels.
Build the claim-to-record chain
Before drafting the letter, create five linked statements:
- The unresolved neurological question.
- The result that changes the answer.
- The analysis or experiment that discriminates among explanations.
- The specialist consequence.
- The boundary that prevents overuse.
Map those statements to the abstract, figures, results, discussion, data record, and cover letter. If one surface changes the claim type, fix the manuscript before submission.
Prepare the reviewable submission checklist
- Confirm article type and current limits on the live JNNP author page.
- Use the appropriate EQUATOR guideline for the design.
- Reconcile ethics, consent, registration, protocol, funding, conflicts, contributions, related work, and data or code access.
- For diagnostic and prediction work, report intended use, reference standard, calibration, validation, and failure cases.
- For mechanistic work, separate evidence for pathway involvement from evidence for causal necessity or sufficiency.
- Follow the current submit link from the official site rather than assuming a portal route.
Readiness check
Run the scan against the requirements while they're in front of you.
See score, top issues, and journal-fit signals before you submit.
Editorial sequence without false prediction
Review function | What must be legible | What authors can control |
|---|---|---|
Intake | Complete files and consistent declarations | Cross-file audit |
Editorial fit | Neurological consequence and audience | Answer-first framing |
Specialist review | Phenotype, method, analysis, alternatives, and limits | Evidence trace and reporting |
Revision closure | Responses reflected in every artifact | Propagation audit |
This table describes dependencies, not reviewer sentiment or a fixed schedule.
Failure modes a format pass cannot repair
Phenotype drift. Inclusion criteria define one population while the discussion names another. Tighten the claim or strengthen validation.
A method becomes the protagonist. Explain the neurological inference the method makes possible and why existing approaches could not resolve it.
Prediction is confused with decision value. Report calibration, threshold consequences, comparison with current practice, and external performance where needed.
A compelling case becomes population evidence. Keep rare or illustrative cases at the level their design supports.
Neuropsychiatric interpretation outruns measurement. Distinguish observed behavior or symptom scores from a broader mechanistic claim.
A specialist reader test
Give the abstract and first figure to a reader who knows the disease area but not the technique. Ask them to identify the represented phenotype, main comparison, result, uncertainty, and clinical or biological consequence. If they can name the technique but not the neurological decision, the paper is not yet framed for JNNP.
Manusights uses this test because it reveals a common submission problem: the analysis can be sophisticated while the editorial consequence remains implicit. Making the consequence explicit does not mean inflating it; it means naming the smallest defensible change in understanding or practice.
In our editorial analysis
We begin by classifying the manuscript's primary claim: diagnosis, prognosis, mechanism, treatment, service delivery, or natural history. Each class has a different evidence burden. A diagnostic claim needs an intended-use population and credible reference standard. A prognostic claim needs time, censoring, calibration, and validation. A mechanistic claim needs a discriminating perturbation. A treatment claim needs a comparator, harms, adherence, missingness, and an effect estimate that matches the design. Calling the paper simply “clinically relevant” hides these differences.
Neurological research is particularly vulnerable to endpoint slippage. A biomarker may correlate with severity without predicting progression; a change in a rating scale may not establish functional benefit; imaging may localize disease without explaining mechanism. We therefore trace every conclusion to its represented endpoint and ask what competing interpretation remains. The strongest submission makes that restraint visible before reviewers have to request it.
Worked example: biomarker to prognosis
For a proposed prognostic biomarker, state the clinical starting point, outcome horizon, competing events, missing samples, assay reproducibility, model specification, and validation setting. Show calibration and decision relevance, not discrimination alone. If samples were collected after treatment decisions or from a referral-enriched cohort, disclose how that changes transportability. A development-only association should not become a clinic-ready prediction claim in the title or cover letter.
Match claim type to evidence
Claim type | Minimum inspectable artifact | Frequent overreach |
|---|---|---|
Diagnostic | Intended-use cohort, reference standard, error table | Case-control separation is presented as clinical accuracy |
Prognostic | Time horizon, calibration, validation, missingness | Association becomes individualized prediction |
Mechanistic | Perturbation, controls, alternative pathway test | Localization or correlation becomes causation |
Treatment | Prespecified outcome, comparator, effect and harms | Surrogate movement becomes patient benefit |
Service delivery | Workflow, denominator, implementation dependency | One centre's throughput becomes universal feasibility |
Use the artifact as an editing device. If the minimum evidence cannot fit into one clear figure or table, the claim is probably not yet ready to carry the title. That mismatch should be repaired before the abstract, cover letter, or submission form repeats it.
Use recent articles to test the claim boundary
The recent JNNP articles below cover population epidemiology, genetic-disease imaging, and neurosurgical management. They are useful comparison points because each asks a different kind of neurological question. A population estimate depends on case definition, ascertainment, geography, and uncertainty. An imaging study depends on phenotype, measurement validity, timing, comparison groups, and whether the image supports diagnosis, prognosis, or mechanism. A management paper depends on patient selection, intervention context, outcomes, harms, and follow-up.
Place your manuscript beside the closest evidence shape and identify the record a specialist would inspect first. For epidemiology, that may be the denominator and ascertainment flow. For imaging or biomarker work, it may be a validation table rather than the most visually striking image. For management research, it may be the outcome-and-harms table stratified by the factors that determined treatment.
The comparison should expose overreach, not encourage imitation. If a development sample is narrated like validated prognosis, or a selected surgical series is narrated like a general treatment rule, narrow the claim before polishing the title. Conversely, if the design genuinely resolves a neurological decision but that consequence is buried after technique, move the decision and its boundary into the abstract and first evidence-bearing figure. Recent articles provide a calibration surface; the manuscript still has to earn its own inference.
Recent JNNP article shapes checked while testing the guide's neurological evidence map:
- Global ALS epidemiology: https://doi.org/10.1136/jnnp-2026-338675
- Genetic frontotemporal dementia imaging: https://doi.org/10.1136/jnnp-2025-337186
- Giant intracranial aneurysm management: https://doi.org/10.1136/jnnp-2026-338459
Official sources accessed August 26, 2026.
- JNNP author information, BMJ.
- JNNP journal, BMJ.
- BMJ Author Hub, BMJ.
- EQUATOR Network.
Submit if
- A neurological, neurosurgical, or neuropsychiatric question clearly owns the paper.
- Phenotype, comparison, result, and limitation agree across surfaces.
- Required ethical, reporting, registration, and data records are complete.
- The first figure carries evidence rather than only context.
Think Twice If
- The technique remains more important than the neurological conclusion.
- A development sample supports a general clinical claim without an external validation table.
- The abstract blurs association, prediction, mechanism, and treatment.
- A reviewer must infer critical phenotype or analysis details.
Frequently asked questions
JNNP is a fit when neurological, neurosurgical, or neuropsychiatric evidence changes a specialist scientific or clinical question and the inference is supported by the design.
Verify the live article type, reporting, ethics, data, declarations, and submission route on JNNP's official author page.
Make the neurological consequence the owner and show how the other discipline supplies evidence rather than creating a second competing protagonist.
No. It helps authors interpret readiness; current official instructions remain controlling.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Your manuscript is never used to train any model.